Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

News
71 - 80of about 655 News
71 - 80of about 655 News
October 27, 2020
Bayer appoints Dr. Christian Rommel as new Head of Pharmaceuticals Research and Development
READ MORE
October 26, 2020
Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy
READ MORE
October 23, 2020
Not intended for U.S. and UK Media
FDA approves FoundationOne®CDx as companion diagnostic for Vitrakvi™ (larotrectinib) to aid in identifying NTRK fusion-positive patients
READ MORE
October 23, 2020
Not intended for U.S. and UK Media – Data from Phase III FIDELIO-DKD study presented at the American Society of Nephrology (ASN)’s Kidney Week 2020
Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
READ MORE
October 14, 2020
Not intended for U.S. and UK Media
Combination of copanlisib and rituximab significantly prolonged progression-free survival of patients with relapsed indolent non-Hodgkin's Lymphoma
READ MORE
October 12, 2020
Not intended for U.S. and UK Media - American Society of Nephrology (ASN)’s Kidney Week 2020 Reimagined:
Finerenone Phase III FIDELIO-DKD study in chronic kidney disease and type 2 diabetes to be presented as late-breaking clinical trial at ASN 2020
READ MORE
September 30, 2020
Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
READ MORE
September 28, 2020
Not intended for U.S. and UK Media
Bayer’s XtendFlex Soybeans Gain Final Key Regulatory Approval
READ MORE
September 17, 2020
ESMO Virtual Congress 2020:
New data reinforce strong clinical profile of Vitrakvi™ for patients of all ages with TRK Fusion Cancer including lung and thyroid tumors
READ MORE
September 15, 2020
Not intended for U.S. and UK Media
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
READ MORE
71 - 80of about 655 News
71 - 80of about 655 News

 

Subscribe To Our Investor News Email Alerts

Ad-Hoc Releases

Discover Bayer's Latest Ad-Hoc Releases

read more